Johnson & Johnson must pay more than $42 million to a Massachusetts man who alleges that he developed mesothelioma, a rare ...

New Brunswick, New Jersey-based Johnson & Johnson (JNJ) primarily focuses on drug discovery and manufacturing but has a diversified business model. With a market cap of $402.8 billion, Johnson & ...

A Boston jury awarded a Massachusetts family $42.6 million in a lawsuit against Johnson & Johnson, claiming the company's ...

Johnson & Johnson (NYSE:JNJ) is included among the 10 Best Dividend Stocks to Buy for Retirement. Johnson & Johnson (NYSE:JNJ) stands out as a financially strong company, being one of only two firms ...

The big appeal of Johnson & Johnson over the years has been that it's a relatively safe stock to own, and it also offers an attractive dividend yield of 2.8% -- the S&P 500 average is just over 1.5%.

Johnson & Johnson’s revenue growth of 16% to $95 billion over the last twelve months, compared to $82 billion in 2019, 2. a 1.5% fall in its total shares outstanding to 2.6 billion, partly ...

Johnson & Johnson shares climbed Friday after the conglomerate behind Band-Aid, Neutrogena and a coronavirus vaccine announced plans to split into two companies. (Richard Drew/AP) ...